Feature: Clinical Trial Reporting in the United States: Limitations of Strained Resources
View web version
Clinical Trial Reporting in the United States: Limitations of Strained Resources
Guidelines and technology are changing, but as the number of clinical trials increases, ensuring that trials are reported will be an increasingly difficult task.
Most Popular
How Should Maintenance Therapy for Multiple Myeloma Be Prescribed?
Age Correlates With Incidence of RCC Among Pediatric Patients With Renal Malignancy

Why you may not be making an impact on the ER

Hormone therapy may not be right for certain MBC patients. Consider an MOA that targets the estrogen receptor.

Sponsored By: AstraZeneca 3134307 Last Updated 12/15

Latest News
Study Highlights Importance of Achieving CR After Intensive Therapy for AML
No Induction Therapy Superior to Another for Higher-risk AML, MDS
Condensed HDAC Schedule Superior to Standard Schedule in AML
Higher Idarubicin Dose During Consolidation Improves Leukemia-free Survival in AML
Brentuximab Vedotin Superior to Standard of Care Options in CTCL

Want to receive emails specific to your profession and specialty? Click here to complete your profile.

If you were sent this by a colleague and wish to subscribe to Weekly highlights, please click here.

To unsubscribe from the Weekly Highlights click here.
To manage your entire Cancer Therapy Advisor profile login to your account.

You are subscribed as: %%EMAIL%%

To contact Haymarket Media for general questions or unsubscribe problems, please reply to this email.

All Cancer Therapy Advisor newsletters are sent from the domain "email.cancertherapyadvisor.com". When configuring e-mail or spam filter rules, please use this domain name.

© 2016 Haymarket Media Inc
275 7th Avenue, 10th Floor
New York, NY 10001